Rivaroxaban for the treatment of superficial vein thrombosis, experience at King's College Hospital

被引：4
|
作者：
Clapham, Rachel E. [1 ]
Speed, Victoria [1 ,2 ]
Czuprynska, Julia [1 ]
Gazes, Anna [1 ]
Guppy, Simon [1 ]
Patel, Raj K. [1 ]
Rea, Catherine [1 ]
Vadher, Bipin [1 ]
Arya, Roopen [1 ]
Roberts, Lara N. [1 ]
机构：
[1] Kings Coll Hosp NHS Fdn Trust, Kings Thrombosis Ctr, Dept Haematol Med, London, England
[2] Kings Coll London, Inst Phar maceut Sci, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2022年 / 196卷 / 01期
关键词：
rivaroxaban; superficial vein thrombosis; anticoagulants; factor Xa inhibitor; DIAGNOSIS;
D O I：
10.1111/bjh.17757
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E3 / E6
页数：4
相关论文
共 50 条
  • [21] Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
    Jorgensen, Camilla Tovik
    Braekkan, Sigrid Kufaas
    Forsund, Eli
    Pettersen, Heidi Hassel
    Tjonnfjord, Eirik
    Ghanima, Waleed
    Tavoly, Mazdak
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (02) : 526 - 533
  • [22] Remarkable regression of massive deep vein thrombosis in response to intensive oral rivaroxaban treatment
    Koitabashi N.
    Niwamae N.
    Taguchi T.
    Ohyama Y.
    Takama N.
    Kurabayashi M.
    Thrombosis Journal, 13 (1)
  • [23] Superficial vein thrombosis of the leg veins - A systematic Review - Part 2: Treatment
    Wienert, Volker
    Gerontopoulou, Stefania Aglaia
    Rass, Knuth
    PHLEBOLOGIE, 2022, 51 (01) : 10 - 20
  • [24] Recent advances in the treatment of superficial vein thrombosis and extracranial carotid artery stenosis
    Bauersachs, R. M.
    Kuhlencordt, P. J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (05) : 168 - 171
  • [25] Tinzaparin in intermediate dose for the treatment of superficial vein thrombosis: Results from an observational multicenter studySeVEN study
    Giannoukas, Athanasios
    Karathanos, Christos
    Nikolakopoulos, Konstantinos
    Georgiadis, George S.
    Maltezos, Chrisostomos
    Ioannou, Christos
    Vasdekis, Spyros
    Trelopoulos, Georgios
    PHLEBOLOGY, 2018, 33 (09) : 636 - 645
  • [26] Treatment of deep vein thrombosis with rivaroxaban and its potential to prevent the post-thrombotic syndrome
    Antignani, Pier Luigi
    Allegra, Claudio
    Fareed, Jawed
    INTERNATIONAL ANGIOLOGY, 2019, 38 (01) : 17 - 21
  • [27] Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis
    Haonan Zhou
    Mingdong Wu
    Shixiong Yu
    Han Xia
    Wu Yu
    Kai Huang
    Yikuan Chen
    BMC Gastroenterology, 23
  • [28] Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis
    Zhou, Haonan
    Wu, Mingdong
    Yu, Shixiong
    Xia, Han
    Yu, Wu
    Huang, Kai
    Chen, Yikuan
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [29] A Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin for Deep Vein Thrombosis (DVT) Treatment in Ethiopia
    Derseh, Manaye Tamrie
    Solomon, Kiflom
    Tamene, Wasihun
    Beneberu, Wosenie
    Yayehrad, Ashagrachew Tewabe
    Ambaye, Abyou Seyfu
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2021, 13 : 821 - 834
  • [30] Triethylene tetramine dihydrochloride (trientine) in children with Wilson disease: experience at King's College Hospital and review of the literature
    Taylor, Rachel M.
    Chen, Yuan
    Dhawan, Anil
    EUROPEAN JOURNAL OF PEDIATRICS, 2009, 168 (09) : 1061 - 1068
12345